CA
NXGN

Clearstead Advisors’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Clearstead Advisors’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,500
Closed -$27K – 1398
2022
Q3 		$27K Hold
1,500
– – ﹤0.01% 723
2022
Q2 		$26K Buy
+1,500
New +$28.6K ﹤0.01% 745

Other funds holding NXGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Clearstead Advisors's NXGN Position: Q4 2022 in Review

Clearstead Advisors sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2022, closing a stake of 1,500 shares — an estimated $27K sold.

Clearstead Advisors first reported a position in NXGN in Q2 2022 and held it in 2 quarters. The position peaked at $27K in Q3 2022. 212 funds tracked by Wall St. Rank hold NXGN as of Q4 2022.

  • Clearstead Advisors reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Clearstead Advisors sold 1,500 NextGen Healthcare, Inc. Common Stock shares in Q4 2022, an estimated $27K.
  • Clearstead Advisors first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Clearstead Advisors's NextGen Healthcare, Inc. Common Stock position peaked at $27K in Q3 2022.
  • 212 funds tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2022.

Based on Clearstead Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.